Journal of Cutaneous and Aesthetic Surgery
Print this page
Email this page
Small font size
Default font size
Increase font size
Home About us Current issue Archives Instructions Submission Subscribe Editorial Board Partners Contact e-Alerts Login 


 
   Table of Contents     
CORRESPONDENCE  
Year : 2014  |  Volume : 7  |  Issue : 2  |  Page : 137-138
Re: Propranolol for infantile haemangiomas: Early experience from a tertiary center


Department of Surgery, Uttar Pradesh Rural Institute of Medical Sciences and Research, Saifai, Etawah, Uttar Pradesh, India

Click here for correspondence address and email

Date of Web Publication7-Aug-2014
 

How to cite this article:
Pandey A, Singh SP, Verma R, Gupta V. Re: Propranolol for infantile haemangiomas: Early experience from a tertiary center. J Cutan Aesthet Surg 2014;7:137-8

How to cite this URL:
Pandey A, Singh SP, Verma R, Gupta V. Re: Propranolol for infantile haemangiomas: Early experience from a tertiary center. J Cutan Aesthet Surg [serial online] 2014 [cited 2019 Apr 20];7:137-8. Available from: http://www.jcasonline.com/text.asp?2014/7/2/137/138372


Dear Editor,

We read with interest the article by Pandey et al., [1] on the use of propranolol in patients of haemangioma. It is indeed a common problem of much concern to the parents of the affected child. Since its first use in 2008, [2] the use of propranolol has increased by leaps and bounds, mostly claiming good response.

The peculiarity of this particular study appears to be its use in non-involuting congenital haemangioma (NICH), which had not been mentioned previously. We believe that the response to propranolol of NICH should have been studied separately. Almost all studies have evaluated the role of propranolol for infantile haemangioma (IH). NICH has not been found to be responsive to propranolol. [3] Thus, this study appears to be having a basic flaw in its design.

The response to the treatment does not clearly state whether the non-responders were of NICH or IH. Besides this, there has been no classification of haemangiomas into superficial, deep and mixed type. Mostly, it is the superficial type, which responds to treatment. [4] Whether propranolol produces same results in all types is not clear. Though there is some description that superficial lesions responded better than the other haemangiomas, it has not been supported by statistical analysis. What we have noticed is that propranolol is better suited for superficial type rather than other haemangiomas.

Although the authors have carefully looked for the possible complications of propranolol by clinical and biochemical evaluation, there has been no mention of serum potassium levels, which have been reported to be deranged in case of propranolol use in form of hyperkalaemia. [5]

The response in ulcerated haemangioma is also not very clear. Was propranolol the only treatment used or was it a combination? This needs some elaboration in this study.

We believe that the conclusions, as stated by the authors, do not match, especially for NICH. There has been a confusion as the title indicates use of propranolol for IH whereas the study includes NICH as well.

It would be great if the authors share their views about our concerns.

 
   References Top

1.Pandey V, Tiwari P, Gangopadhyay AN, Gupta DK, Sharma SP, Kumar V. Propranolol for infantile haemangiomas: Experience from a tertiary center. J Cutan Aesthet Surg 2014;7:37-41.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51.  Back to cited text no. 2
    
3.Boucek RJ Jr, Kirsh AL, Majesky MW, Perkins JA. Propranolol responsiveness in vascular tumors is not determined by qualitative differences in adrenergic receptors. Otolaryngol Head Neck Surg 2013;149:772-6.   Back to cited text no. 3
    
4.Pandey A, Gangopadhyay AN, Gopal SC, Kumar V, Sharma SP, Gupta DK, et al. Twenty years' experience of steroids in infantile hemangioma - a developing country's perspective. J Pediatr Surg 2009;44:688-94.  Back to cited text no. 4
    
5.Pavlakovic H, Kietz S, Lauerer P, Zutt M, Lakomek M. Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics 2010;126:e1589-93.  Back to cited text no. 5
    

Top
Correspondence Address:
Anand Pandey
Department of Surgery, Uttar Pradesh Rural Institute of Medical Sciences and Research, Saifai, Etawah, Uttar Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0974-2077.138372

Rights and Permissions




 

Top
  
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed1228    
    Printed12    
    Emailed0    
    PDF Downloaded86    
    Comments [Add]    

Recommend this journal